Elucid Bioimaging Inc. — Form D
Elucid Bioimaging Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-22. The offering totals $80.0M, of which $36.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-22
- Form: D
- Accession: 0002080612-25-000007
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $36.5M
- Remaining: $43.5M
- Investors: 9
- Date of first sale: 2025-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-561638
Issuer
- Name: Elucid Bioimaging Inc.
- CIK: 0001585931
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 399 Boylston Street, BOSTON, MA, 02116
- Phone: 617-329-9487
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Shamiram Feinglass | Director | Boston, MA |
| Kelly Huang | Director | Boston, MA |
| Scott Huennekens | Director | Boston, MA |
| Richard Kuntz | Director | Boston, MA |
| Michael Lesh | Director | Boston, MA |
| Evan Melrose | Director | Boston, MA |
| Rajesh Panda | Director | Boston, MA |
| Kelly Huang | Executive Officer | Boston, MA |
| Blake Richards | Executive Officer | Boston, MA |
| Blake Richards | Director | Boston, MA |
| Scott Huennekens | Executive Officer | Boston, MA |
| Robert Braun | Director | Boston, MA |
| Andrew J Buckler | Executive Officer | Wenham, MA |
Other filings by this issuer (2)
More